CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $79,000 | -73.5% | 43,890 | +23.5% | 0.03% | -73.6% |
Q2 2020 | $298,000 | +70.3% | 35,530 | +6.2% | 0.11% | +69.2% |
Q1 2020 | $175,000 | +9.4% | 33,440 | +14.3% | 0.06% | +54.8% |
Q4 2019 | $160,000 | +73.9% | 29,260 | +55.6% | 0.04% | +200.0% |
Q3 2019 | $92,000 | – | 18,810 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $3,107,000 | 1.71% |
ETF MANAGERS GROUP, LLC | 14,138,998 | $8,534,000 | 0.17% |
Ikarian Capital, LLC | 948,526 | $584,000 | 0.09% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 318,668 | $196,000 | 0.03% |
Platform Technology Partners | 45,000 | $28,000 | 0.01% |
XTX Topco Ltd | 34,476 | $21,000 | 0.01% |
PINNACLE ASSOCIATES LTD | 947,083 | $583,000 | 0.01% |
Penserra Capital Management LLC | 537,236 | $330,000 | 0.01% |
Mirae Asset Global Investments Co., Ltd. | 4,070,006 | $2,506,000 | 0.01% |
Tekla Capital Management LLC | 154,310 | $95,000 | 0.00% |